Range Cancer Therapeutics Etf (CNCR)

  • $

$14.4

(-4.91%)

past 7 days

1D

1W

1M

1Y

3Y

5Y

Performance

  • $14.335
    $ 14.75
    $14
    downward going graph

    0.45%

    Downside

    Day's Volatility :2.81%

    Upside

    2.37%

    downward going graph
  • $9.22
    $ 17.96
    $14
    downward going graph

    35.97%

    Downside

    52 Weeks Volatility :48.66%

    Upside

    19.82%

    downward going graph

Expense Ratio

0.79%

AUM

$16.49M

Returns

PeriodRange Cancer Therapeutics EtfS&P500
3 Months
-15.55%
4.28%
6 Months
38.48%
16.46%
1 Year
10.77%
26.09%
3 Years
-52.24%
26.16%

Top 10 Holdings

Geron Corporation
Geron Corporation
2.74%
Enliven Therapeutics Inc.
Enliven Therapeutics Inc.
2.74%
Iteos Therapeutics Inc
Iteos Therapeutics Inc
2.25%
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC
2.2%
Acrivon Therapeutics Inc. Common Stock
Acrivon Therapeutics Inc. Common Stock
2.2%
Nuvation Bio Inc
Nuvation Bio Inc
1.93%
NantKwest Inc
NantKwest Inc
1.87%
Cullinan Oncology LLC
Cullinan Oncology LLC
1.84%
Erasca Inc
Erasca Inc
1.71%
Lyell Immunopharma Inc
Lyell Immunopharma Inc
1.68%

  • Market Cap

  • Assets

About the ETF

About Range Cancer Therapeutics Etf

About Range Cancer Therapeutics Etf

Range Cancer Therapeutics Etf has 1.0 ETFs with total asset size of $16.49M

Discover more

Frequently Asked Questions

What is Range Cancer Therapeutics Etf (CNCR) share price today?

Can Indians buy Range Cancer Therapeutics Etf shares?

How can I buy Range Cancer Therapeutics Etf shares from India?

Can Fractional shares of Range Cancer Therapeutics Etf be purchased?

What are the documents required to start investing in Range Cancer Therapeutics Etf stocks?

What are today’s High and Low prices of Range Cancer Therapeutics Etf?

What is today’s market capitalisation of Range Cancer Therapeutics Etf?

What is the 52 Week High and Low Range of Range Cancer Therapeutics Etf?

How much percentage Range Cancer Therapeutics Etf is down from its 52 Week High?

How much percentage Range Cancer Therapeutics Etf is up from its 52 Week low?